Skip to Main Content

Author Details

Christiane E Angermann
University and University Hospital Wurzburg
1976
245
48
PMIDPaper TitleJournal TitlePublished Year
36254693Impact of empagliflozin on decongestion in acute heart failure: the EMPULSE trial.Eur Heart J2023
37670404Remote heart failure management guided by pulmonary artery pressure home monitoring: rewriting the future?Eur Heart J2023
37591524Real-time pulmonary artery pressure monitoring in heart failure patients: an updated cost-effectiveness analysis.ESC Heart Fail2023
37678961Global Variations According to Sex in Patients Hospitalized for Heart Failure in the REPORT-HF Registry.JACC Heart Fail2023
35648270Prevalence and prognostic impact of chronic kidney disease and anaemia across ACC/AHA precursor and symptomatic heart failure stages.Clin Res Cardiol2023
37220769Remote pulmonary artery pressure monitoring in heart failure care: part of the new normal?Lancet2023
36974770Impact of left ventricular ejection fraction phenotypes on healthcare resource utilization in hospitalized heart failure: a secondary analysis of REPORT-HF.Eur J Heart Fail2023
37038330The win ratio method in heart failure trials: lessons learnt from EMPULSE.Eur J Heart Fail2023
36718715Longer-Term Effects of Remote Patient Management Following Hospital Discharge After Acute Systolic Heart Failure: The Randomized E-INH Trial.JACC Heart Fail2023
36196060Association of time-to-intravenous furosemide with mortality in acute heart failure: data from REPORT-HF.Eur J Heart Fail2023
34516969A global perspective of racial differences and outcomes in patients presenting with acute heart failure.Am Heart J2022
35840352Effect of adaptive servo ventilation on central sleep apnea and sleep structure in systolic heart failure patients: polysomnography data from the SERVE-HF major sub study.J Sleep Res2022
35377706Effects of Empagliflozin on Symptoms, Physical Limitations, and Quality of Life in Patients Hospitalized for Acute Heart Failure: Results From the EMPULSE Trial.Circulation2022
35429091Quality of life assessed 6â¿¿months after hospitalisation for acute heart failure: an analysis from REPORT-HF (international REgistry to assess medical Practice with lOngitudinal obseRvation for Treatment of Heart Failure).Eur J Heart Fail2022
35393622Global disparities in prescription of guideline-recommended drugs for heart failure with reduced ejection fraction.Eur Heart J2022
35486314Digital Technologies to Support Better Outcome and Experience of Care in Patients with Heart Failure.Curr Heart Fail Rep2022
36066557Renal effects of empagliflozin in patients hospitalized for acute heart failure: from the EMPULSE trial.Eur J Heart Fail2022
36054647Effects of remote haemodynamic-guided heart failure management in patients with different subtypes of pulmonary hypertension: insights from the MEMS-HF study.Eur J Heart Fail2022
34913270Sex-specific bimodal clustering of left ventricular ejection fraction in patients with acute heart failure.ESC Heart Fail2022
35246723Pulmonary artery sensor system pressure monitoring to improve heart failure outcomes (PASSPORT-HF): rationale and design of the PASSPORT-HF multicenter randomized clinical trial.Clin Res Cardiol2022
35064730Regional differences in precipitating factors of hospitalization for acute heart failure: insights from the REPORT-HF registry.Eur J Heart Fail2022
35228754The SGLT2 inhibitor empagliflozin in patients hospitalized for acute heart failure: a multinational randomized trial.Nat Med2022
34738340Less loop diuretic use in patients on sacubitril/valsartan undergoing remote pulmonary artery pressure monitoring.ESC Heart Fail2022
34332057Dynamics of Left Ventricular Myocardial Work in Patients Hospitalized for Acute Heart Failure.J Card Fail2021
33544152Heart and brain interactions : Pathophysiology and management of cardio-psycho-neurological disorders.Herz2021
33647999[Care of patients with chronic heart failure: an interdisciplinary challenge].Dtsch Med Wochenschr2021
33839078Global Differences in Burden and Treatment of Ischemic Heart Disease in Acute Heart Failure: REPORT-HF.JACC Heart Fail2021
33609072Sodium-glucose co-transporter 2 inhibition in patients hospitalized for acute decompensated heart failure: rationale for and design of the EMPULSE trial.Eur J Heart Fail2021
33496189Trajectories of Left Ventricular Ejection Fraction After Acute Decompensation for Systolic Heart Failure: Concomitant Echocardiographic and Systemic Changes, Predictors, and Impact on Clinical Outcomes.J Am Heart Assoc2021
33934554Adaptive anti-myocardial immune response following hospitalization for acute heart failure.ESC Heart Fail2021
34313541A genetic variant alters the secondary structure of the lncRNA H19 and is associated with dilated cardiomyopathy.RNA Biol2021
30957867Efficacy of a web-based intervention for improving psychosocial well-being in patients with implantable cardioverter-defibrillators: the randomized controlled ICD-FORUM trial.Eur Heart J2020
32087174Post-discharge prognosis of patients admitted to hospital for heart failure by world region, and national level of income and income disparity (REPORT-HF): a cohort study.Lancet Glob Health2020
31784904Bioprofiles and mechanistic pathways associated with Cheyne-Stokes respiration: insights from the SERVE-HF trial.Clin Res Cardiol2020
31951323Biomarkers in patients with heart failure and central sleep apnoea: findings from the SERVE-HF trial.ESC Heart Fail2020
32040032Implementing structured heart failure outpatient monitoring and care in real life.J Cardiovasc Med (Hagerstown)2020
31913404Global Differences in Characteristics, Precipitants, and Initial Management of Patients Presenting With Acute Heart Failure.JAMA Cardiol2020
32003157Syncopes and clinical outcome in heart failure: results from prospective clinical study data in Germany.ESC Heart Fail2020
33074507Terminale Herzinsuffizienz: Neue Ansätze der ambulanten Therapie : Kardiologie -- Autoren: G. Güder, C. Angermann, G. Ertl.MMW Fortschr Med2020
33328035Mortality and morbidity 1 year after stopping a remote patient management intervention: extended follow-up results from the telemedical interventional management in patients with heart failure II (TIM-HF2) randomised trial.Lancet Digit Health2020
32710857Correction to: Post-discharge prognosis of patients admitted to hospital for heart failure by world region, and national level of income and income disparity (REPORT-HF): a cohort study.Lancet Glob Health2020
32592227Pulmonary artery pressure-guided therapy in ambulatory patients with symptomatic heart failure: the CardioMEMS European Monitoring Study for Heart Failure (MEMS-HF).Eur J Heart Fail2020
31218793Association of serious adverse events with Cheyne-Stokes respiration characteristics in patients with systolic heart failure and central sleep apnoea: A SERVE-Heart Failure substudy analysis.Respirology2020
30553401The omega-3 index in patients with heart failure: A prospective cohort study.Prostaglandins Leukot Essent Fatty Acids2019
31908619The trialist's perspective: what do you need to prove for remote monitoring devices to be approved?Eur Heart J Suppl2019
31908617Implantable devices for heart failure monitoring: the CardioMEMSâ¿¢ system.Eur Heart J Suppl2019
31658482[Hyperkalemia - Pathophysiology, prognostic significance and treatment options].Dtsch Med Wochenschr2019
30097684Symptom patterns and clinical outcomes in women versus men with systolic heart failure and depression.Clin Res Cardiol2019
31139330Prevalence of cardiovascular risk factors and diseases in patients with multiple myeloma undergoing autologous peripheral blood stem cell transplantation.Oncotarget2019
30784226Vitamin D deficiency in patients with diastolic dysfunction or heart failure with preserved ejection fraction.ESC Heart Fail2019
  • 1 - 50 of 245

Recommended Authors

Duke University Medical Center, NC Duke Clinical Research Institute
Career Start Year 2017
Number of shared co-authors 0
University of Florida Gainesville
Career Start Year 2015
Number of shared co-authors 0
Duke University Medical Center, Duke Clinical Research Institute
Career Start Year 2010
Number of shared co-authors 3
The Ohio State University Wexner Medical Center
Career Start Year 2006
Number of shared co-authors 2
Gladstone Institutes
Career Start Year 2004
Number of shared co-authors 2
Brigham and Women's Hospital, Harvard Medical School
Career Start Year 2003
Number of shared co-authors 11
Yale School of Medicine
Career Start Year 1999
Number of shared co-authors 8
Hospital of the University of Pennsylvania
Career Start Year 1998
Number of shared co-authors 1
Duke University Hospital
Career Start Year 1997
Number of shared co-authors 2
University of Florida
Career Start Year 1997
Number of shared co-authors 0
Mayo Clinic
Career Start Year 1997
Number of shared co-authors 0
Duke University School of Medicine
Career Start Year 1992
Number of shared co-authors 13
The Ohio State University
Career Start Year 1990
Number of shared co-authors 13
INSERM UMR-S , Universite de Paris Cite
Career Start Year 1989
Number of shared co-authors 15
Mission Hospital
Career Start Year 1989
Number of shared co-authors 5
Tufts Medical Center
Career Start Year 1989
Number of shared co-authors 8
NYU Grossman School of Medicine
Career Start Year 1988
Number of shared co-authors 4
Perelman School of Medicine at the University of Pennsylvania
Career Start Year 1988
Number of shared co-authors 8
University of Pennsylvania Perelman School of Medicine
Career Start Year 1987
Number of shared co-authors 9
Istituto di Ricerche Farmacologiche Mario Negri IRCCS
Career Start Year 1986
Number of shared co-authors 4
Department of Medicine Morehouse School of Medicine Atlanta GE.
Career Start Year 1985
Number of shared co-authors 5
Vanderbilt University Medical Center
Career Start Year 1980
Number of shared co-authors 13
Thomas Jefferson University
Career Start Year 1980
Number of shared co-authors 12
Gregorio Maranon University Hospital
Career Start Year 1980
Number of shared co-authors 3
Biostatistics and Prevention Institute, University of Zurich
Career Start Year 1976
Number of shared co-authors 3
University of California
Career Start Year 1976
Number of shared co-authors 10
National and Kapodistrian University of Athens
Career Start Year 1973
Number of shared co-authors 6
Northwestern University Feinberg School of Medicine
Career Start Year 1972
Number of shared co-authors 10
Mayo Clinic College of Medicine and Science
Career Start Year 1969
Number of shared co-authors 5
University of California (Davis) Medical Center
Career Start Year 1961
Number of shared co-authors 5

Collaborators

University Hospital Wurzburg
Co-authored papers 100
Co-authored papers 23
Vanderbilt University School of Medicine
Co-authored papers 17
University of Bergen
Co-authored papers 13
National and Kapodistrian University of Athens, Attikon University Hospital
Co-authored papers 12
Duke-NUS Medical School
Co-authored papers 12
Linkoping University
Co-authored papers 12
Novartis Pharma AG
Co-authored papers 12
Novartis Pharma AG
Co-authored papers 11
Alexandria University
Co-authored papers 11
British Heart Foundation Centre of Research Excellence, University of Glasgow
Co-authored papers 11
Novartis Pharma
Co-authored papers 11
El Cruce Hospital by Florencio Varela, Lezica Cardiovascular Institute
Co-authored papers 10
Charite University Medicine, Berlin Institute of Health (BIH)
Co-authored papers 9
Co-authored papers 6
Cardiology University of California San Francisco (UCSF)
Co-authored papers 6
Saint Luke's Mid America Heart Institute, University of Missouri-Kansas City
Co-authored papers 6
Co-authored papers 3
Co-authored papers 3
University Hospital Frankfurt am Main
Co-authored papers 2
Co-authored papers 2
University of Missouri-Kansas City School of Medicine
Co-authored papers 2
Co-authored papers 2
Co-authored papers 2
University Hospital Frankfurt am Main, University Hospital Wurzburg
Co-authored papers 2
Co-authored papers 2
University of Toronto
Co-authored papers 1
Co-authored papers 1
German Cancer Research Center (DKFZ)
Co-authored papers 1
Co-authored papers 1